|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0030705,
umls-concept:C0205234,
umls-concept:C0205265,
umls-concept:C0238198,
umls-concept:C0449258,
umls-concept:C0871261,
umls-concept:C0939537,
umls-concept:C1555582,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2603343,
umls-concept:C2911692
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2007-10-8
|
|
pubmed:abstractText |
This study aimed to investigate the outcome of patients with advanced gastrointestinal stromal tumors (GISTs) exhibiting focal disease progression during imatinib therapy, treated by surgical resection and imatinib continuation.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1436-3291
|
|
pubmed:author |
pubmed-author:Al-BatranSalah-EddinSE,
pubmed-author:DüxMarkusM,
pubmed-author:DechowClaudiusC,
pubmed-author:FischerThomasT,
pubmed-author:HartmannJoerg ThomasJT,
pubmed-author:HeidelFlorianF,
pubmed-author:IzbickiJacob RobertJR,
pubmed-author:JägerElkeE,
pubmed-author:KrausThomasT,
pubmed-author:StoehlmacherJanJ,
pubmed-author:WardelmannEvaE
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
10
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
145-52
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:17922091-Adult,
pubmed-meshheading:17922091-Aged,
pubmed-meshheading:17922091-Antineoplastic Agents,
pubmed-meshheading:17922091-Disease Progression,
pubmed-meshheading:17922091-Disease-Free Survival,
pubmed-meshheading:17922091-Dose-Response Relationship, Drug,
pubmed-meshheading:17922091-Drug Resistance, Neoplasm,
pubmed-meshheading:17922091-Female,
pubmed-meshheading:17922091-Follow-Up Studies,
pubmed-meshheading:17922091-Gastrointestinal Stromal Tumors,
pubmed-meshheading:17922091-Humans,
pubmed-meshheading:17922091-Male,
pubmed-meshheading:17922091-Middle Aged,
pubmed-meshheading:17922091-Mutation,
pubmed-meshheading:17922091-Piperazines,
pubmed-meshheading:17922091-Proto-Oncogene Proteins c-kit,
pubmed-meshheading:17922091-Pyrimidines,
pubmed-meshheading:17922091-Retrospective Studies,
pubmed-meshheading:17922091-Salvage Therapy,
pubmed-meshheading:17922091-Survival Rate,
pubmed-meshheading:17922091-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Focal progression in patients with gastrointestinal stromal tumors after initial response to imatinib mesylate: a three-center-based study of 38 patients.
|
|
pubmed:affiliation |
Department of Hematology and Oncology, Krankenhaus Nordwest, Steinbacher Hohl 2-26, 60488 Frankfurt am Main, Germany.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
